To assess effects of interactions with stromal cells on MM cell responses to the MEK/Chk1 inhibitor regimen, MM cells stably expressing luciferase in co-culture with HS-5 cells were used to monitor MM cell viability. The gene discussed is CHEK1; the disease is Miyoshi myopathy.